| Bacillus anthracis |
Anthrax lethal factor |
Potency |
1.6 |
nM |
None |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
5'-nucleotidase |
Inhibition |
15.0 |
% |
10.1016/j.ejmech.2013.10.053 |
| Homo sapiens |
A549 |
Inhibition |
19.22 |
% |
10.1016/j.bmcl.2016.03.024 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Amyloid-beta A4 protein |
IC50 |
50000.0 |
nM |
10.1016/j.bmcl.2015.11.022 |
| Homo sapiens |
Amyloid-beta A4 protein |
IC50 |
nan |
None |
10.1016/j.bmcl.2015.11.022 |
| Homo sapiens |
Amyloid-beta A4 protein |
Inhibition |
17.2 |
% |
10.1016/j.bmcl.2015.11.022 |
| Homo sapiens |
Amyloid-beta A4 protein |
Inhibition |
20.1 |
% |
10.1016/j.bmcl.2017.01.050 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
12505.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
19952.62 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
707.9 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10890.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
0.7 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
25.1 |
nM |
None |
| Homo sapiens |
HCEC |
Activity |
nan |
None |
10.1016/j.ejmech.2013.10.053 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-9.97 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-3.47 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase MLL |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Cmax |
6000.0 |
nM |
10.1124/dmd.111.043356 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
32642.7 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver microsome |
CL |
0.0013 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
CL |
0.0037 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
CL |
0.0084 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
CL |
0.0164 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
KmH |
8.4 |
uM |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
KmH |
36.7 |
uM |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
KmL |
1348.0 |
uM |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
KmL |
5876.0 |
uM |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
VmaxH |
137.9 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
VmaxH |
309.4 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
VmaxL |
4904.0 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
Liver microsome |
VmaxL |
7429.0 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Lysosomal alpha-glucosidase |
Potency |
39506.8 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Inhibition |
5.0 |
% |
10.1016/j.bmcl.2017.01.050 |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase B |
Inhibition |
7.29 |
% |
10.1016/j.bmcl.2017.01.050 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
21599.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
26530.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NCI-H157 |
Activity |
40.0 |
% |
10.1016/j.ejmech.2013.10.053 |
| Homo sapiens |
NCI-H157 |
Activity |
70.0 |
% |
10.1016/j.ejmech.2013.10.053 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
74978.0 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Serum |
Stability |
nan |
% |
10.1016/j.bmc.2011.11.065 |
| Homo sapiens |
SH-SY5Y |
Activity |
81.2 |
% |
10.1021/acs.jmedchem.0c02129 |
| Homo sapiens |
SH-SY5Y |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c02129 |
| Homo sapiens |
SH-SY5Y |
EC50 |
3750.0 |
nM |
10.1016/j.ejmech.2019.111695 |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
707.9 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
0.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
70794.6 |
nM |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
CL |
0.0002 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
KmH |
284.8 |
uM |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-1 |
VmaxH |
45.2 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-10 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
CL |
0.0016 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Km |
777700.0 |
nM |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-6 |
Vmax |
1244.0 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-7 |
CL |
0.0017 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-7 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-7 |
Km |
432300.0 |
nM |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-7 |
Vmax |
740.2 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-8 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
CL |
0.0008 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
CL |
0.0424 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
KmH |
6.0 |
uM |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
KmL |
419.4 |
uM |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
VmaxH |
254.5 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-9 |
VmaxL |
340.4 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B15 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B17 |
CL |
0.0033 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B17 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B17 |
Km |
128600.0 |
nM |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B17 |
Vmax |
428.7 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B4 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
CL |
0.0007 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Km |
2384000.0 |
nM |
10.1124/dmd.111.043356 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Vmax |
1769.0 |
pmol/min/g |
10.1124/dmd.111.043356 |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
3981.1 |
nM |
None |
| Mus musculus |
Arachidonate 15-lipoxygenase |
IC50 |
34000.0 |
nM |
10.1016/j.bmcl.2016.10.033 |
| Mus musculus |
Arachidonate 15-lipoxygenase |
Inhibition |
nan |
% |
10.1016/j.bmcl.2016.10.033 |
| Mus musculus |
BV-2 |
Activity |
69.7 |
% |
10.1016/j.ejmech.2022.114597 |
| Mus musculus |
BV-2 |
Activity |
76.85 |
% |
10.1016/j.ejmech.2022.114597 |
| Mus musculus |
BV-2 |
Activity |
83.03 |
% |
10.1016/j.ejmech.2022.114597 |
| Mus musculus |
HT-22 |
MTC |
200.0 |
uM |
10.1016/s0960-894x(00)00122-0 |
| Mus musculus |
HT-22 |
PC50 |
70.4 |
uM |
10.1016/s0960-894x(00)00122-0 |
| Mus musculus |
HT-22 |
Ratio |
2.8 |
None |
10.1016/s0960-894x(00)00122-0 |
| Mus musculus |
HT-22 |
TC50 |
200.0 |
uM |
10.1016/s0960-894x(00)00122-0 |
| Mus musculus |
Mus musculus |
Activity |
1.6 |
None |
10.1021/acs.jmedchem.0c02129 |
| Mus musculus |
Mus musculus |
Activity |
39.0 |
% |
10.1021/acs.jmedchem.0c02129 |
| Mus musculus |
Mus musculus |
Activity |
43.9 |
% |
10.1021/acs.jmedchem.0c02129 |
| Mus musculus |
Mus musculus |
Activity |
46.2 |
% |
10.1021/acs.jmedchem.0c02129 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c02129 |
| Mus musculus |
Mus musculus |
Survival |
80.0 |
% |
10.1016/s0960-894x(00)00122-0 |
| Mus musculus |
Mus musculus |
Temperature |
-2.4 |
degrees C |
10.1016/s0960-894x(00)00122-0 |
| Mus musculus |
N2a |
Activity |
90.0 |
% |
10.1021/acs.jnatprod.9b00322 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
12589.3 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
17782.8 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Mus musculus |
ScN2a |
IC50 |
1000.0 |
nM |
10.1021/jm070688r |
| Mycobacterium tuberculosis |
Protein RecA |
EC50 |
2950.0 |
nM |
None |
| Mycobacterium tuberculosis |
Replicative DNA helicase |
AC50 |
2753.0 |
nM |
None |
| Mycobacterium tuberculosis |
Replicative DNA helicase |
AC50 |
3243.0 |
nM |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Plasma |
Activity |
nan |
None |
10.1021/jm300681r |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3013.1 |
nM |
None |
| Rattus norvegicus |
5'-nucleotidase |
Inhibition |
29.0 |
% |
10.1016/j.ejmech.2013.10.053 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Aorta |
EC50 |
nan |
None |
10.1016/j.bmcl.2009.04.120 |
| Rattus norvegicus |
Aorta |
EC50 |
nan |
None |
10.1021/jm8007008 |
| Rattus norvegicus |
Aorta |
Emax |
nan |
None |
10.1016/j.bmcl.2009.04.120 |
| Rattus norvegicus |
Cortical neurone |
Activity |
85.2 |
% |
10.1016/j.ejmech.2017.11.084 |
| Rattus norvegicus |
Cortical neurone |
Activity |
86.7 |
% |
10.1016/j.ejmech.2017.11.084 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
H9c2 |
Inhibition |
nan |
% |
10.1039/C1MD00041A |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Liver |
t1/2 |
nan |
None |
10.1016/j.bmc.2011.11.065 |
| Rattus norvegicus |
Liver microsomes |
IC50 |
17000.0 |
nM |
10.1021/jm8007008 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
PC-12 |
Activity |
1.17 |
% |
10.1016/j.bmcl.2017.02.006 |
| Rattus norvegicus |
PC-12 |
Activity |
1.85 |
% |
10.1016/j.bmcl.2017.02.006 |
| Rattus norvegicus |
PC-12 |
Activity |
1.92 |
% |
10.1016/j.bmcl.2017.02.006 |
| Rattus norvegicus |
PC-12 |
Activity |
25.28 |
U/ml |
10.1016/j.bmcl.2015.06.090 |
| Rattus norvegicus |
PC-12 |
Activity |
25.6 |
% |
10.1021/np0603931 |
| Rattus norvegicus |
PC-12 |
Activity |
36.83 |
U/ml |
10.1016/j.bmcl.2015.06.090 |
| Rattus norvegicus |
PC-12 |
Activity |
47.8 |
% |
10.1021/np0603931 |
| Rattus norvegicus |
PC-12 |
Activity |
53.1 |
% |
10.1021/np0603931 |
| Rattus norvegicus |
PC-12 |
Activity |
55.5 |
% |
10.1021/np0603931 |
| Rattus norvegicus |
PC-12 |
Activity |
58.41 |
% |
10.1016/j.ejmech.2022.114315 |
| Rattus norvegicus |
PC-12 |
Activity |
70.3 |
% |
10.1016/j.ejmech.2022.114315 |
| Rattus norvegicus |
PC-12 |
Activity |
74.3 |
% |
10.1021/np100008r |
| Rattus norvegicus |
PC-12 |
Activity |
78.05 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
PC-12 |
Activity |
80.25 |
% |
10.1016/j.ejmech.2022.114315 |
| Rattus norvegicus |
PC-12 |
Activity |
83.3 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
PC-12 |
Activity |
86.9 |
% |
10.1021/np100008r |
| Rattus norvegicus |
PC-12 |
Activity |
93.2 |
% |
10.1016/j.bmcl.2009.04.120 |
| Rattus norvegicus |
PC-12 |
Activity |
95.1 |
% |
10.1016/j.bmcl.2017.02.006 |
| Rattus norvegicus |
PC-12 |
Activity |
97.69 |
U/L |
10.1016/j.bmcl.2015.06.090 |
| Rattus norvegicus |
PC-12 |
Activity |
140.79 |
U/L |
10.1016/j.bmcl.2015.06.090 |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1016/j.ejmech.2015.03.038 |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1016/j.ejmech.2017.11.040 |
| Rattus norvegicus |
PC-12 |
EC50 |
9200.0 |
nM |
10.1021/acs.jnatprod.6b00954 |
| Rattus norvegicus |
Plasma |
Cmax |
20000.0 |
nM |
10.1039/C1MD00041A |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
12.77 |
% |
10.1016/j.ejmech.2022.114315 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
28.52 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
30.08 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
34.2 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
34.46 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
36.14 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
37.31 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
52.5 |
% |
10.1016/j.bmc.2008.08.075 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
58.33 |
% |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2013.04.015 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2015.08.057 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2017.09.028 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm300681r |
| Rattus norvegicus |
Rattus norvegicus |
ED |
3.0 |
mg kg-1 |
10.1039/C1MD00041A |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
32000.0 |
nM |
10.1016/j.bmcl.2003.09.077 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
79432.8 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
10.6 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
15.64 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.13 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.16 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
4.46 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.4195 |
None |
10.1101/2020.04.03.023846 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.bmcl.2014.05.050 |
| None |
ADMET |
CL |
0.0018 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| None |
ADMET |
CL |
0.0036 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| None |
ADMET |
CL |
0.0453 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| None |
ADMET |
CL |
0.0785 |
mL.min-1.g-1 |
10.1124/dmd.111.043356 |
| None |
ADMET |
Cp |
5.0 |
uM |
10.1016/j.bmcl.2016.10.033 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1124/dmd.111.043356 |
| None |
ADMET |
ED50 |
nan |
mg.kg-1 |
10.1016/j.bmcl.2003.09.077 |
| None |
ADMET |
Inhibition |
2.4 |
% |
10.1016/j.bmcl.2016.03.024 |
| None |
ADMET |
KmH |
7.4 |
uM |
10.1124/dmd.111.043356 |
| None |
ADMET |
KmH |
8.7 |
uM |
10.1124/dmd.111.043356 |
| None |
ADMET |
KmL |
1363.0 |
uM |
10.1124/dmd.111.043356 |
| None |
ADMET |
KmL |
1466.0 |
uM |
10.1124/dmd.111.043356 |
| None |
ADMET |
log Pe |
-3.52 |
None |
10.1016/j.bmc.2011.11.065 |
| None |
ADMET |
permeability |
0.12 |
mole fraction |
10.1016/j.bmc.2011.11.065 |
| None |
ADMET |
TIME |
0.05 |
hr |
10.1021/jm8007008 |
| None |
ADMET |
VmaxH |
336.5 |
pmol/min/g |
10.1124/dmd.111.043356 |
| None |
ADMET |
VmaxH |
696.0 |
pmol/min/g |
10.1124/dmd.111.043356 |
| None |
ADMET |
VmaxL |
2396.0 |
pmol/min/g |
10.1124/dmd.111.043356 |
| None |
ADMET |
VmaxL |
5265.0 |
pmol/min/g |
10.1124/dmd.111.043356 |
| None |
Molecular identity unknown |
Activity |
82.0 |
% |
10.1016/j.bmc.2008.08.075 |
| None |
Molecular identity unknown |
Activity |
nan |
None |
10.1016/j.bmc.2008.08.075 |
| None |
Molecular identity unknown |
Potency |
44668.4 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
70794.6 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Activity |
33.04 |
% |
10.1016/j.bmcl.2016.03.094 |
| None |
NON-PROTEIN TARGET |
Activity |
72.3 |
% |
10.1016/j.ejmech.2015.08.057 |
| None |
NON-PROTEIN TARGET |
Activity |
76.6 |
% |
10.1016/j.bmcl.2015.06.090 |
| None |
NON-PROTEIN TARGET |
Activity |
76.89 |
% |
10.1016/j.bmcl.2015.06.090 |
| None |
NON-PROTEIN TARGET |
Activity |
77.7 |
% |
10.1016/j.ejmech.2015.08.057 |
| None |
NON-PROTEIN TARGET |
Activity |
85.8 |
% |
10.1016/j.ejmech.2015.08.057 |
| None |
NON-PROTEIN TARGET |
Activity |
86.7 |
% |
10.1016/j.ejmech.2015.08.057 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/jm070688r |
| None |
NON-PROTEIN TARGET |
Inhibition |
1.43 |
% |
10.1016/j.bmcl.2016.03.024 |
| None |
NON-PROTEIN TARGET |
Inhibition |
24.77 |
% |
10.1016/j.bmcl.2015.06.090 |
| None |
NON-PROTEIN TARGET |
Inhibition |
25.47 |
% |
10.1016/j.bmcl.2015.06.090 |
| None |
NON-PROTEIN TARGET |
Inhibition |
28.06 |
% |
10.1016/j.bmcl.2015.06.090 |
| None |
NON-PROTEIN TARGET |
Inhibition |
37.9 |
% |
10.1016/j.bmc.2008.08.075 |
| None |
NON-PROTEIN TARGET |
Inhibition |
42.45 |
% |
10.1016/j.bmcl.2015.06.090 |
| None |
NON-PROTEIN TARGET |
Inhibition |
43.7 |
% |
10.1016/j.bmc.2008.08.075 |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1016/j.bmcl.2016.10.033 |
| None |
NON-PROTEIN TARGET |
K |
1.4 |
10'10/M/s |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
K |
2.93 |
10'3/M/s |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
K |
3.0 |
10'10/M/s |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
K |
27.5 |
10'6/M/s |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
K |
30.0 |
10'6/M/s |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
K |
298.0 |
10'9/M/s |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
K |
nan |
None |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
Potency |
2.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
26.6 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
3346.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Ratio |
2.14 |
None |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
Ratio |
28.7 |
None |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
Ratio |
39.0 |
None |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
Ratio |
61.1 |
None |
10.1016/j.bmcl.2014.01.045 |
| None |
NON-PROTEIN TARGET |
Ratio |
306.0 |
None |
10.1016/j.bmcl.2014.01.045 |
| None |
No relevant target |
Activity |
0.72 |
uMequiv/uM |
10.1016/j.bmcl.2017.01.050 |
| None |
No relevant target |
Activity |
3096.0 |
umol/L |
10.1016/j.bmcl.2014.05.050 |
| None |
No relevant target |
Activity |
nan |
None |
10.1016/j.ejmech.2017.11.084 |
| None |
No relevant target |
IC50 |
54.4 |
ug.mL-1 |
10.1016/j.bmcl.2016.03.024 |
| None |
No relevant target |
IC50 |
4500.0 |
nM |
10.1016/j.bmc.2020.115463 |
| None |
No relevant target |
IC50 |
9000.0 |
nM |
10.1016/j.bmc.2020.115463 |
| None |
No relevant target |
IC50 |
19700.0 |
nM |
10.1016/j.bmcl.2014.05.050 |
| None |
No relevant target |
IC50 |
213700.0 |
nM |
10.1016/j.bmcl.2014.05.050 |
| None |
No relevant target |
IC50 |
3570000.0 |
nM |
10.1021/acs.jmedchem.0c00887 |
| None |
No relevant target |
Inhibition |
50.0 |
% |
10.1016/j.ejmech.2017.07.026 |
| None |
No relevant target |
Inhibition |
71.0 |
% |
10.1016/j.ejmech.2017.07.026 |
| None |
No relevant target |
Inhibition |
nan |
% |
10.1016/j.bmcl.2016.10.033 |
| None |
No relevant target |
K |
3.16 |
10'6/M/s |
10.1016/j.bmcl.2014.01.045 |
| None |
No relevant target |
LogD |
0.78 |
None |
10.1021/jm8007008 |
| None |
No relevant target |
LogP |
0.86 |
None |
10.1016/j.bmcl.2016.10.033 |
| None |
No relevant target |
LogP |
1.28 |
None |
10.1021/jm8007008 |
| None |
No relevant target |
LogP |
1.44 |
None |
10.1016/j.bmc.2011.11.065 |
| None |
No relevant target |
logPi |
nan |
None |
10.1021/jm8007008 |
| None |
No relevant target |
pKa |
6.9 |
None |
10.1021/jm8007008 |
| None |
No relevant target |
Ratio |
139.0 |
None |
10.1016/j.bmcl.2014.01.045 |
| None |
No relevant target |
Stability |
nan |
% |
10.1016/j.bmc.2011.11.065 |
| None |
Platelet |
IC50 |
250000.0 |
nM |
10.1021/jm300681r |
| None |
Platelet |
IC50 |
850000.0 |
nM |
10.1021/jm300681r |
| None |
Platelet |
Inhibition |
11.5 |
% |
10.1021/jm300681r |
| None |
Platelet |
Inhibition |
32.4 |
% |
10.1016/j.bmc.2008.08.075 |
| None |
Platelet |
Inhibition |
36.12 |
% |
10.1021/jm300681r |
| None |
Radical scavenging activity |
Activity |
72.0 |
10'3/M/s |
10.1039/C2MD20287E |
| None |
Radical scavenging activity |
IC50 |
27000.0 |
nM |
10.1021/np0603931 |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Activity |
0.6 |
% |
10.1021/jm070688r |
| None |
Unchecked |
Activity |
5.7 |
% |
10.1021/jm070688r |
| None |
Unchecked |
EC50 |
4610.0 |
nM |
10.1016/j.ejmech.2019.111695 |
| None |
Unchecked |
ED50 |
nan |
mg.kg-1 |
10.1016/j.bmcl.2003.09.077 |
| None |
Unchecked |
IC50 |
250.0 |
nM |
10.1021/jm070688r |
| None |
Unchecked |
IC50 |
18700.0 |
nM |
10.1016/j.bmc.2020.115866 |
| None |
Unchecked |
IC50 |
29300.0 |
nM |
10.1016/j.bmc.2020.115866 |
| None |
Unchecked |
IC50 |
29300.0 |
nM |
10.1016/j.bmcl.2003.07.016 |
| None |
Unchecked |
IC50 |
250000.0 |
nM |
10.1016/j.bmcl.2006.09.005 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
1000.0 |
nM |
None |
| None |
Unchecked |
Potency |
28183.8 |
nM |
None |
| None |
Unchecked |
Potency |
89125.1 |
nM |
None |
| None |
Unchecked |
Potency |
100000.0 |
nM |
None |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1016/j.bmcl.2017.01.050 |
| None |
Unchecked |
V0 |
nan |
None |
10.1016/j.bmc.2020.115866 |